Table 3.
Comparison of Data from the 1997, 2000, 2002, and 2003 Addressing Tobacco in Managed Care Surveysa
| Activity | 1997 Respondents (N = 323), % Yes | 2000 Respondents (N = 85), % Yes | 2002 Respondents (N = 152), % Yes | 2003 Respondents (N = 160), % Yes | P Valueb |
| Plan provides full coverage for | |||||
| Any pharmacotherapy for smoking cessation | 25.0 | 20.0 | 88.8 | 87.8 | <.001 |
| Bupropion (as Zyban) | 17.6 | 37.2 | 41.1 | 29.5 | .10 |
| Any over-the-counter NRT | 6.6 | 14.9 | 8.6 | 9.6 | <.001 |
| NRT only with program enrollment | 25.0 | 26.0 | 10.8 | 19.3 | .01 |
| Plan provides full coverage for | |||||
| Telephone counseling | 32.8 | 36.8 | 51.7 | 42.3 | .07 |
| Face-to-face counseling | 26.6 | 23.6 | 41.1 | 35.9 | .04 |
| Group counseling or classes | 35.7 | 37.0 | 15.9 | 21.2 | .002 |
| Self-help materials | 54.1 | 56.6 | 25.8 | 45.5 | <.001 |
| Any behavioral therapy or pharmacotherapy | 75.0 | 94.4 | 98.0 | 96.2 | <.001 |
| Plan is able to identify individual members (some or all) who smoke | 14.9 | 27.1 | 71.7 | 91.1 | <.001 |
| Plan has a specific strategy to address smoking cessation | |||||
| During adolescence | 17.6 | 24.2 | 28.9 | 32.1 | .46 |
| During pregnancy | 45.0 | 59.0 | 56.6 | 68.6 | .08 |
| During postpartum visits | 13.6 | 30.5 | 46.7 | 46.8 | .03 |
| During pediatric visits | 15.8 | 17.3 | 28.3 | 29.5 | .10 |
| After myocardial infarction | 21.7 | 27.2 | 46.7 | 56.4 | <.001 |
| During treatment for chronic illness | 22.6 | 31.3 | 52.0 | 64.7 | <.001 |
| Plan funds a full- or part-time tobacco control program staff position | 7.7 | 23.5 | 19.1 | 16.1 | <.001 |
NRT indicates nicotine replacement therapy.
Although the survey instruments used in the 1997, 2000, 2002, and 2003 Addressing Tobacco in Managed Care surveys were not identical, a core set of questions on pharmacotherapies, behavioral health, and smoking cessation strategies remained unchanged.
Proportions were compared for 1997 and 2003 surveys using the chi-square test; results were considered statistically significant at P ≤.05.